Cargando…

Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort

BACKGROUND AND OBJECTIVE: Stent-assisted coil embolization is a well-established treatment of intracranial wide-necked aneurysms. The Neuroform Atlas Stent System is a new generation microstent designed to enhance coil support, conformability, deliverability, and improve deployment accuracy. We pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankowitz, Brian T, Hanel, Ricardo, Jadhav, Ashutosh P, Loy, David N, Frei, Donald, Siddiqui, Adnan H, Puri, Ajit S, Khaldi, Ahmad, Turk, Aquilla S, Malek, Adel M, Sauvageau, Eric, Hetts, Steven W, Zaidat, Osama O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703120/
https://www.ncbi.nlm.nih.gov/pubmed/30670625
http://dx.doi.org/10.1136/neurintsurg-2018-014455
_version_ 1783445373509959680
author Jankowitz, Brian T
Hanel, Ricardo
Jadhav, Ashutosh P
Loy, David N
Frei, Donald
Siddiqui, Adnan H
Puri, Ajit S
Khaldi, Ahmad
Turk, Aquilla S
Malek, Adel M
Sauvageau, Eric
Hetts, Steven W
Zaidat, Osama O
author_facet Jankowitz, Brian T
Hanel, Ricardo
Jadhav, Ashutosh P
Loy, David N
Frei, Donald
Siddiqui, Adnan H
Puri, Ajit S
Khaldi, Ahmad
Turk, Aquilla S
Malek, Adel M
Sauvageau, Eric
Hetts, Steven W
Zaidat, Osama O
author_sort Jankowitz, Brian T
collection PubMed
description BACKGROUND AND OBJECTIVE: Stent-assisted coil embolization is a well-established treatment of intracranial wide-necked aneurysms. The Neuroform Atlas Stent System is a new generation microstent designed to enhance coil support, conformability, deliverability, and improve deployment accuracy. We present the 1-year efficacy and angiographic results of the Humanitarian Device Exemption (HDE) cohort from the Atlas Investigational Device Exemption (IDE) clinical trial. METHOD: The Atlas IDE trial is a prospective, multicenter, single-arm, open-label study of unruptured wide-necked intracranial aneurysms treated with the Neuroform Atlas stent and approved coils. The primary efficacy endpoint was the rate of 12-month complete aneurysm angiographic occlusion (Raymond class I) without target aneurysm retreatment or significant parent artery stenosis (>50%) at the target location. The primary safety endpoint was the rate of major ipsilateral stroke or neurological death within 12 months. Imaging core laboratory and Clinical EventsCommittee adjudicated the primary endpoints. RESULTS: 30 patients were enrolled at eight US centers, with 27 patients completing the 12-month angiographic follow-up. The mean age was 59.4±11.8 years and 24/30 patients (80%) were women. The mean aneurysm size was 5.3±1.7 mm and the dome:neck ratio was 1.1±0.2. Procedural technical success of Neuroform Atlas Stent deployment was 100%. 27 patients completed 12-month angiographic follow-up and 30 patients completed their 6-month follow-up. When applying the last observation carried forward method, the primary efficacy endpoint was observed in 26/30 patients (86.7%, 95% CI 69.3% to 96.2%) compared with 25/27 patients (92.6%, 95% CI 75.7% to 99.1%) who completed the 12-month angiographic follow-up. The primary safety endpoint of stroke occurred in one patient (3.3%), who made a complete clinical recovery at discharge. There were no neurological deaths. CONCLUSION: The Neuroform Atlas stent in conjunction with coils demonstrated a high rate of complete aneurysm occlusion at 12-month angiographic follow-up, with an improved safety profile in the HDE cohort. CLINICAL TRIAL.GOV REGISTRATION NUMBER: NCT0234058; Results
format Online
Article
Text
id pubmed-6703120
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67031202019-09-02 Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort Jankowitz, Brian T Hanel, Ricardo Jadhav, Ashutosh P Loy, David N Frei, Donald Siddiqui, Adnan H Puri, Ajit S Khaldi, Ahmad Turk, Aquilla S Malek, Adel M Sauvageau, Eric Hetts, Steven W Zaidat, Osama O J Neurointerv Surg New Devices and Techniques BACKGROUND AND OBJECTIVE: Stent-assisted coil embolization is a well-established treatment of intracranial wide-necked aneurysms. The Neuroform Atlas Stent System is a new generation microstent designed to enhance coil support, conformability, deliverability, and improve deployment accuracy. We present the 1-year efficacy and angiographic results of the Humanitarian Device Exemption (HDE) cohort from the Atlas Investigational Device Exemption (IDE) clinical trial. METHOD: The Atlas IDE trial is a prospective, multicenter, single-arm, open-label study of unruptured wide-necked intracranial aneurysms treated with the Neuroform Atlas stent and approved coils. The primary efficacy endpoint was the rate of 12-month complete aneurysm angiographic occlusion (Raymond class I) without target aneurysm retreatment or significant parent artery stenosis (>50%) at the target location. The primary safety endpoint was the rate of major ipsilateral stroke or neurological death within 12 months. Imaging core laboratory and Clinical EventsCommittee adjudicated the primary endpoints. RESULTS: 30 patients were enrolled at eight US centers, with 27 patients completing the 12-month angiographic follow-up. The mean age was 59.4±11.8 years and 24/30 patients (80%) were women. The mean aneurysm size was 5.3±1.7 mm and the dome:neck ratio was 1.1±0.2. Procedural technical success of Neuroform Atlas Stent deployment was 100%. 27 patients completed 12-month angiographic follow-up and 30 patients completed their 6-month follow-up. When applying the last observation carried forward method, the primary efficacy endpoint was observed in 26/30 patients (86.7%, 95% CI 69.3% to 96.2%) compared with 25/27 patients (92.6%, 95% CI 75.7% to 99.1%) who completed the 12-month angiographic follow-up. The primary safety endpoint of stroke occurred in one patient (3.3%), who made a complete clinical recovery at discharge. There were no neurological deaths. CONCLUSION: The Neuroform Atlas stent in conjunction with coils demonstrated a high rate of complete aneurysm occlusion at 12-month angiographic follow-up, with an improved safety profile in the HDE cohort. CLINICAL TRIAL.GOV REGISTRATION NUMBER: NCT0234058; Results BMJ Publishing Group 2019-08 2019-01-22 /pmc/articles/PMC6703120/ /pubmed/30670625 http://dx.doi.org/10.1136/neurintsurg-2018-014455 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle New Devices and Techniques
Jankowitz, Brian T
Hanel, Ricardo
Jadhav, Ashutosh P
Loy, David N
Frei, Donald
Siddiqui, Adnan H
Puri, Ajit S
Khaldi, Ahmad
Turk, Aquilla S
Malek, Adel M
Sauvageau, Eric
Hetts, Steven W
Zaidat, Osama O
Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort
title Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort
title_full Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort
title_fullStr Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort
title_full_unstemmed Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort
title_short Neuroform Atlas Stent System for the treatment of intracranial aneurysm: primary results of the Atlas Humanitarian Device Exemption cohort
title_sort neuroform atlas stent system for the treatment of intracranial aneurysm: primary results of the atlas humanitarian device exemption cohort
topic New Devices and Techniques
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703120/
https://www.ncbi.nlm.nih.gov/pubmed/30670625
http://dx.doi.org/10.1136/neurintsurg-2018-014455
work_keys_str_mv AT jankowitzbriant neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT hanelricardo neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT jadhavashutoshp neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT loydavidn neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT freidonald neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT siddiquiadnanh neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT puriajits neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT khaldiahmad neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT turkaquillas neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT malekadelm neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT sauvageaueric neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT hettsstevenw neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort
AT zaidatosamao neuroformatlasstentsystemforthetreatmentofintracranialaneurysmprimaryresultsoftheatlashumanitariandeviceexemptioncohort